← USPTO Patent Applications

CRISPR ENZYMES AND SYSTEMS

Application US20260092266A1 Kind: A1 Apr 02, 2026

Inventors

Feng Zhang, Han Altae-Tran, Soumya Kannan

Abstract

Described herein are engineered, non-naturally occurring systems and compositions comprising multimeric CRISPR-Cas complexes comprising a β-CASP polypeptide, a plurality of Cas polypeptides, and a guide molecule, packaging and delivery systems thereof, and methods of use thereof, for modifying target polynucleotides. In addition, described herein are engineered, non-naturally occurring systems and compositions comprising a class of small Cas proteins (Type II-B, II-C, and II-D Cas proteins) and methods of modifying target sequences using the Type II-B, II-C, II-D Cas proteins and systems thereof.

CPC Classifications

C12N 9/222 C12N 15/111 C12N 15/8203 C12N 15/86 C12N 15/902 C07K 2319/09 C12N 2310/20

Filing Date

2025-11-13

Application No.

19388533